Predictors of successful treatment of respiratory distress with aerosolized calfactant
Michelle Hojnicki(Johns Hopkins University), Scott O. Guthrie(Jackson-Madison County General Hospital), Dinushan C. Kaluarachchi(University of Wisconsin–Madison), George Albert(University of Rochester Medical Center), Stephen D. Minton(Utah Valley Regional Medical Center), Ann H. Ross(Hackensack Meridian Health), Henry A. Zapata(University of Wisconsin–Madison), Prem Fort(Johns Hopkins University), Gregory E. Wilding(University at Buffalo, State University of New York)
Cited by 5
Related Papers
Recombinant Human Superoxide Dismutase Enhances the Effect of Inhaled Nitric Oxide in Persistent Pulmonary Hypertension
|American Journal of Respiratory and Critical Care Medicine|2001|93
Aerosolized Calfactant for Newborns With Respiratory Distress: A Randomized Trial
|PEDIATRICS|2020|91
Interfacility transfers for US ischemic stroke and TIA, 2006–2014
|Neurology|2018|40